Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03132298 · ClinicalTrials.gov registry record · NA
Effects of a Single-session Implicit Theories of Personality Intervention on Early Adolescent Psychopathology
A NA study of Depressive Symptoms and Anxiety Symptoms, sponsored by Harvard University.
- Completed
- Registry status
- NA
- Development phase
- 96
- Enrollment target
- 1
- Study location
NCT03132298: Completed NA study of Depressive Symptoms and Anxiety Symptoms, sponsored by Harvard University.
NCT03132298 is a NA study of Depressive Symptoms and Anxiety Symptoms that has completed, run by Harvard University. The registered enrollment target is 96 participants, below the 260-participant average among 60 other Depressive Symptoms trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03132298, a NA study of Depressive Symptoms and Anxiety Symptoms, has completed, sponsored by Harvard University.
- COMPLETED
- Registry status
- NA
- Development phase
- 96 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of the project is to test whether a single-session intervention teaching incremental theories of personality, or the belief that one's personality is malleable, can strengthen recovery from social stress and reduce the development of anxiety and depression during early adolescence. Results may suggest a scalable, cost-effective approach to improving youths' coping capacities and preventing adverse mental health outcomes over time.
Primary Outcome
the Children's Depression Inventory, a 27-item self-report questionnaire that measures cognitive, affective, and behavioral symptoms of depression. Items are scored from 0-2, and scores range from 0 to 44; higher scores indicate greater symptom severity. The CDI is reliable and valid. It can distinguish youths with more or less severe depressive symptoms, as well as youths at risk for depression from non-depressed youths. Suicide- and self-harm related questions were removed for the purposes of
Conditions Studied
Interventions
- OTHER Control Program
- OTHER Implicit Theories of Personality Program
Study Locations (1)
Massachusetts
- Harvard University - Cambridge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2015-08-17 |
| Est. Completion | 2016-10-30 |
| Phase | NA |
What the finished NCT03132298 record still lists
NCT03132298 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 260-participant average among 60 other Depressive Symptoms trials with a reported enrollment target (63% lower).
The record links to 2 conditions, with Depressive Symptoms appearing as the primary indexed condition, and to 2 interventions - of which Control Program is the first listed.
NCT03132298 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03132298 about?
NCT03132298 is a clinical study titled "Effects of a Single-session Implicit Theories of Personality Intervention on Early Adolescent Psychopathology". The goal of the project is to test whether a single-session intervention teaching incremental theories of personality, or the belief that one's personality is malleable, can strengthen recovery from social stress and reduce the development of anxiety and depression during early adolescence. Results ...
What is the current status of trial NCT03132298?
This trial is currently completed. It is a NA study. The enrollment target is 96 participants. The study started on 2015-08-17. Estimated completion is 2016-10-30.
What conditions does trial NCT03132298 study?
This clinical trial studies the following conditions: Depressive Symptoms, Anxiety Symptoms.
What interventions are being tested in trial NCT03132298?
The interventions under investigation include: Control Program (OTHER), Implicit Theories of Personality Program (OTHER).
Who is sponsoring clinical trial NCT03132298?
This trial is sponsored by Harvard University, which has 37 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03132298 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depressive Symptoms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03132298's enrollment target sits among peer trials
96 31st of 60 higher than 30 of 60 other Depressive Symptoms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depressive Symptoms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Caregiver Stress and Sleep Study
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Mood and Thought Process Study
RECRUITING · NA
-
Michigan Men's Diabetes Project III(MenDIII): Mind and Motion
RECRUITING · NA
-
A New Clinical Model for the Engagement of Latinx Youth With Suicidal Behavior
RECRUITING · NA
-
Improving Mood for Adolescents Through Teaming With End-Users in Routine Care (The iMATTER Project)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI